These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37115478)

  • 21. Effects of andrographolide on renal tubulointersticial injury and fibrosis. Evidence of its mechanism of action.
    Liu W; Liang L; Zhang Q; Li Y; Yan S; Tang T; Ren Y; Mo J; Liu F; Chen X; Lan T
    Phytomedicine; 2021 Oct; 91():153650. PubMed ID: 34332282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling.
    Huang F; Zhao Y; Wang Q; Hillebrands JL; van den Born J; Ji L; An T; Qin G
    Front Endocrinol (Lausanne); 2019; 10():441. PubMed ID: 31333586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.
    Sun X; Huang K; Haiming X; Lin Z; Yang Y; Zhang M; Liu P; Huang H
    Clin Sci (Lond); 2020 Jul; 134(13):1573-1592. PubMed ID: 32558900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twist1 downregulation of PGC-1α decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis.
    Liu L; Ning X; Wei L; Zhou Y; Zhao L; Ma F; Bai M; Yang X; Wang D; Sun S
    Theranostics; 2022; 12(8):3758-3775. PubMed ID: 35664054
    [No Abstract]   [Full Text] [Related]  

  • 25. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
    Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
    Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway.
    Lu J; Li XQ; Chen PP; Zhang JX; Li L; Wang GH; Liu XQ; Jiang CM; Ma KL
    Acta Pharmacol Sin; 2024 Feb; 45(2):366-377. PubMed ID: 37770579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
    Zhao D; Jia J; Shao H
    J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.
    Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PGC-1α inhibits the NLRP3 inflammasome via preserving mitochondrial viability to protect kidney fibrosis.
    Nam BY; Jhee JH; Park J; Kim S; Kim G; Park JT; Yoo TH; Kang SW; Yu JW; Han SH
    Cell Death Dis; 2022 Jan; 13(1):31. PubMed ID: 35013155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of TLR4 on PGC-1
    Yuan S; Liu X; Zhu X; Qu Z; Gong Z; Li J; Xiao L; Yang Y; Liu H; Sun L; Liu F
    Oxid Med Cell Longev; 2018; 2018():6296802. PubMed ID: 29861832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1.
    Zhao X; He X; Wei W; Huang K
    Eur J Pharmacol; 2023 May; 947():175671. PubMed ID: 37001578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formononetin Attenuates Renal Tubular Injury and Mitochondrial Damage in Diabetic Nephropathy Partly via Regulating Sirt1/PGC-1α Pathway.
    Huang Q; Chen H; Yin K; Shen Y; Lin K; Guo X; Zhang X; Wang N; Xin W; Xu Y; Gui D
    Front Pharmacol; 2022; 13():901234. PubMed ID: 35645821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats.
    Zang L; Gao F; Huang A; Zhang Y; Luo Y; Chen L; Mao N
    J Pharmacol Sci; 2022 Feb; 148(2):204-213. PubMed ID: 35063135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
    Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
    Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing of angiotensin II type-1 receptor inhibits high glucose-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via inactivation of mTOR/p70S6K signaling pathway.
    Gong Q; Hou F
    Biochem Biophys Res Commun; 2016 Jan; 469(2):183-8. PubMed ID: 26626074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
    Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
    Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA KIFAP3-5:1 inhibits epithelial-mesenchymal transition of renal tubular cell through PRRX1 in diabetic nephropathy.
    Du L; Lu Y; Wang J; Zheng Y; Li H; Liu Y; Wu X; Zhou J; Wang L; He L; Shi J; Xu L; Li X; Lu Q; Yin X
    Cell Biol Toxicol; 2024 Jun; 40(1):47. PubMed ID: 38869718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK; Park SH; Choi YJ; Shin D; Kang YH
    J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy.
    Jiang M; Fan J; Qu X; Li S; Nilsson SK; Sun YBY; Chen Y; Yu D; Liu D; Liu BC; Tang M; Chen W; Ren Y; Nikolic-Paterson DJ; Jiang X; Li J; Yu X
    Front Pharmacol; 2019; 10():880. PubMed ID: 31447676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.